PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15802852-2	2005	The Zn(II) complex showed strong alpha-glucosidase inhibitory activity greater by about eighty times (substrate: maltose) and forty times (substrate: sucrose) compared with acarbose.	Sucrose	150-157	sucrase isomaltase (alpha-glucosidase)	Mus musculus	33-50	
19420711-2	2009	The simultaneous oral administration of the extract at a dose of 1.0 mg/mouse with maltose or sucrose inhibited the postprandial elevation of the plasma glucose and insulin levels and intestinal alpha-glucosidase activities in mice.	Sucrose	94-101	sucrase isomaltase (alpha-glucosidase)	Mus musculus	195-212	
34455958-9	2022	From the in vitro studies, the position and number of the feruloyl substituents on the sucrose core, the aromatic "OH" group, and the diisopropylidene bridges were key determinants of the % inhibition of alpha-glucosidase and alpha-amylase.	Sucrose	87-94	sucrase isomaltase (alpha-glucosidase)	Mus musculus	204-221	
34914943-1	2022	BACKGROUND & AIMS: The sucrase-isomaltase (SI) c.273_274delAG loss-of-function variant is common in Arctic populations and causes congenital sucrase-isomaltase deficiency, an inability to breakdown and absorb sucrose and isomaltose.	Sucrose	209-216	sucrase isomaltase (alpha-glucosidase)	Mus musculus	23-41	
34914943-1	2022	BACKGROUND & AIMS: The sucrase-isomaltase (SI) c.273_274delAG loss-of-function variant is common in Arctic populations and causes congenital sucrase-isomaltase deficiency, an inability to breakdown and absorb sucrose and isomaltose.	Sucrose	209-216	sucrase isomaltase (alpha-glucosidase)	Mus musculus	43-45	
34914943-9	2022	CONCLUSIONS: These results suggest that sucrase-isomaltase constitutes a promising drug target for improvement of metabolic health, and that the health benefits are mediated by reduced dietary sucrose uptake and possibly also by higher levels of circulating acetate.	Sucrose	193-200	sucrase isomaltase (alpha-glucosidase)	Mus musculus	40-58	
32722136-4	2020	The potential as alpha-glucosidase inhibitors of products was evaluated with oral sucrose and lactose tolerance (OSTT and OLTT, respectively) and intestinal sucrose hydrolysis (ISH) tests; the potential as SGLT-1 inhibitors was evaluated using oral glucose tolerance (OGTT), intestinal glucose absorption (IGA), and urinary glucose excretion (UGE) tests.	Sucrose	82-89	sucrase isomaltase (alpha-glucosidase)	Mus musculus	17-34	
32722136-4	2020	The potential as alpha-glucosidase inhibitors of products was evaluated with oral sucrose and lactose tolerance (OSTT and OLTT, respectively) and intestinal sucrose hydrolysis (ISH) tests; the potential as SGLT-1 inhibitors was evaluated using oral glucose tolerance (OGTT), intestinal glucose absorption (IGA), and urinary glucose excretion (UGE) tests.	Sucrose	157-164	sucrase isomaltase (alpha-glucosidase)	Mus musculus	17-34	
29621479-9	2018	In support of this possibility, we reported that acarbose (an alpha-glucosidase inhibitor) prevented sucrose, maltose and Polycose from eliciting CPIR.	Sucrose	101-108	sucrase isomaltase (alpha-glucosidase)	Mus musculus	62-79	
27399232-5	2016	The alpha-glucosidase inhibitory properties of 1 were confirmed in vivo with an oral sucrose tolerance test in normal and hyperglycemic mice (p < 0.05).	Sucrose	85-92	sucrase isomaltase (alpha-glucosidase)	Mus musculus	4-21